# RTOG 1112 (NCT01730937)

> Sorafenib Tosylate With or Without Stereotactic Body Radiation Therapy in Treating Patients With Liver Cancer

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT01730937
- Phase: PHASE3
- Status: COMPLETED
- Sponsor: Radiation Therapy Oncology Group
- Conditions: Adult Primary Hepatocellular Carcinoma; Advanced Adult Primary Liver Cancer; Recurrent Adult Primary Liver Cancer
- Interventions: Sorafenib; stereotactic body radiation therapy
- Enrollment: 193
- Primary outcome: Overall Survival

## Indexed commentary on RTOG 1112 so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- X threads: 109
- YouTube: 7
- Podcasts: 6
- Bluesky threads: 3
- X videos: 3

## Order

Deep, $1,950, price fixed at order: https://www.erudio.com/contact?report=rtog-1112-nct01730937

## Free preview

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT01730937", "email": "<work email>"}; the inbox owner confirms by the emailed link.